CIK 0001439725 · Non-accelerated filer<br>Smaller reporting company
BIODESIX INC
Sign in to watch- Ticker
- BDSX
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203986492
- Phone
- 303-417-0500
- Business address
- 919 WEST DILLON ROAD, LOUISVILLE, CO, 80027
- 4 Option exercise Chief Development Officer acquired 880 shares (option exercise)
- 4 Option exercise Chief Commercial Officer acquired 13,080 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 4,347,840 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Option exercise President & CEO acquired 26,120 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Option exercise CFO, Sec'y & Treasurer acquired 17,289 shares (option exercise)
- 4 Option exercise Director acquired 217,400 shares (option exercise)
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Shareholder vote results
- UPLOAD Other SEC-generated Letter
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market sale Chief Accounting Officer sold 244 shares at $1.48 ($361)
- 4 Open-market sale Chief Development Officer sold 434 shares at $1.48 ($642)
- 4 Open-market sale Chief Commercial Officer sold 468 shares at $1.48 ($692)
- 4 Open-market sale President & CEO sold 3,764 shares at $1.48 ($5,569)
- 4 Open-market sale CFO, Sec'y & Treasurer sold 980 shares at $1.48 ($1,450)
- 144 Insider Sale of Securities
Page 10 of 31 · 602 filings